Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 3/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | DRD5 | P21918 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA9 | Q16790 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL584898 | 0.79 | CA12 (0.53) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL16381756 | 0.77 | CA12 (0.56) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL16539622 | 0.77 | KIF11 (0.41) | DRD1SCN9ADRD5KIF11CYP1A1 | |
| SCHEMBL28224945 | 0.75 | KIF11 (0.52) | SCN9AHDAC8HDAC6KIF11CA12 | |
| SCHEMBL28020022 | 0.73 | GPR3 (0.44) | SCN9AKIF11CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL4411615 | 0.73 | AKR1C3 (0.57) | DRD1SCN9ADRD2DRD4DRD5 | |
| SCHEMBL4418949 | 0.73 | APP (0.54) | AKR1C3AKR1C2KIF11 | |
| SCHEMBL31227778 | 0.73 | AKR1C3 (0.47) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL18001814 | 0.73 | KIF11 (0.57) | DRD1SCN9ADRD2DRD4DRD5 | |
| SCHEMBL17508160 | 0.73 | KIF11 (0.53) | DRD1PTGDR2AKR1C3AKR1C2KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7022868-B2 | Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2006-04-04 | — | — | US | disclosed |
| US-20050258743-A1 | Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2005-11-24 | — | — | US | disclosed |
| US-6906217-B2 | Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2005-06-14 | — | — | US | disclosed |
| US-6790975-B2 | ORGANIC ELECTROLUMINESCENCE; CONDENSATION FROM A CORRESPONDING AMINOBENZALDEHYDE AND A PHOSPHONIC ESTER OR PHOSPHONIUM SALT; YELLOW TO RED LIGHT | SONY CORPORATION (JP) | 2004-09-14 | — | — | US | disclosed |
| US-20030229242-A1 | Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof | JOLED INC. (JP) | 2003-12-11 | — | — | US | disclosed |
| US-20030208089-A1 | Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof | JOLED INC. (JP) | 2003-11-06 | — | — | US | disclosed |
| US-20030149290-A1 | AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | JOLED INC. (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-1191015-A1 | AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH | Sony Corporation (JP) | 2002-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050258743-A1 | Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof | AASDHPPT, AADAT, ALDH7A1 | DRD1 2543/4885SCN9A 1834/4885DRD2 2376/4885 |
| US-20030229242-A1 | Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof | AASDHPPT, AADAT, ALDH7A1 | DRD1 2068/4885SCN9A 1898/4885DRD2 2463/4885 |
| US-20030149290-A1 | AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | AASDHPPT, AADAT, ALDH7A1 | DRD1 2068/4885SCN9A 1898/4885DRD2 2463/4885 |
| US-20030208089-A1 | Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof | AASDHPPT, ALDH7A1, AGPAT5 | DRD1 1982/4885SCN9A 1503/4885DRD2 2978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.